Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC MRX-2843 | 1429882-07-4 | MFCD28502224 | 99.6% | 488.67 g/mol | C29H40N6O | 50 MG
Supplier: Medchemexpress LLC HY10154950MG
MRX-2843 (UNC2371) is an orally active, ATP-competitive dual MERTK and FLT3 tyrosine kinase inhibitor used in preclinical cancer research. Reported enzymatic IC50 values are 1.3 nM for MERTK and 0.64 nM for FLT3. Supplied as a solid with high chemical purity, it is intended for in vitro and in vivo studies of kinase signaling and mechanisms of drug resistance.
- Potent dual inhibition of MERTK and FLT3 with low-nanomolar potency.
- Orally bioavailable type 1 kinase inhibitor suitable for preclinical models.
- High chemical purity supports reproducible research results.
- Supplied as a solid for flexible formulation and dosing.
- Useful for studying kinase signaling pathways and resistance mechanisms.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?